acute l Flashcards
(67 cards)
The peak inci
dence of __in children is between 2 and 5 years of age.
ACUTE LYMPHOBLASTIC LEUKEMIA
, there may be a large mass in the mediastinum
leading to compromise of regional anatomic structures.
T cell ALL
Bone pain, mucocutaneous bleeding
B cell ALL`
most common type of lymphoblast seen
small lymphoblast (1.0 to
2.5 times the size of a normal lymphocyte)
ALL cells can be confused with cells in
AML
are the strongest predic
tor of adverse treatment outcomes for children and adults
Chromosomal translocations are the strongest predic
tor of adverse treatment outcomes for children and adults
mutations involving the NOTCH1 gene,
T-ALL
has the worst prog
nosis among ALLs.
B-lymphoblastic leukemia/
lymphoma with the t(9;22)(q34;q11.2);BCR-ABL1 mutation
(Philadelphia chromosome–positive ALL)
, which has shown success in treating chronic
myeloid leukemia,
Imatinib
in B-lymphoblastic leukemia/
lymphoma is common in childhood B-ALL,
Hyperdiploidy
is a
group of metabolic complications that can occur in patients
with malignancy, most notably lymphomas and leukemias, with
and without treatment of the malignancy
Tumor lysis syndrome
Tumor lysis syndrome is characterized by
hyperkalemia,
hyperphosphatemia, hyperuricemia and hyperuricosuria, and
hypocalcemia.
AML with this translocation has myeloblasts with dysplastic granular cytoplasm, Auer rods, and some maturation
Acute myeloid leukemia with t(8;21)(q22;q22.1);RUNX1/
RUNX1T
Acute myeloid leukemia with inv(16)(p13.1q22) or t(16;16)
(p13.1;q22);CBFB-MYH11.
- Myeloblasts, monoblasts, and promyelocytes IN Pb and bm along with eosinp[hilia with dysplastic changes
- central nervous system is a common site for relapse
- remission rate is good, but only one half of
patients are cured.
characterized by a differentiation block
at the promyelocytic stage.
- Acute promyelocytic leukemia with PML-RARA.
Detection of the 15;17 translocation is sufficient for
diagnosis regardless of blast count
Acute promyelocytic leukemia with PML-RARA
their procoagulant activity initiates
disseminated intravascular coagulation; however, thromboem
bolic events may occur at presentation and during treatment
Acute promyelocytic leukemia with PML-RARA.
“butterfly” or “coin-on-coin” nucleus,
Acute promyelocytic leukemia with PML-RARA.
PML RARA
Treatment
includes all-trans-retinoic acid (ATRA) and arsenic trioxide
induces differentiation of
the malignant promyelocytes
atra
is a rare leukemia (6% of AML cases) that presents with an
increase in monoblasts and immature monocytes
Acute myeloid leukemia with t(9;11)(p22;q23);KMT2A (MLL)
MLLT3.
Typically this disease occurs in children and may be associated
with gingival and skin involvement and/or disseminated intravas
cular coagulation.
Acute myeloid leukemia with t(9;11)(p22;q23);KMT2A (MLL)
MLLT3
a,l with myodeplasia-related changes are has specific MDS-associated cytogenetic abnormality except
del(9q).
There must also be absence of AML with recurrent genetic ab
normalities, NPM1 and biallelic mutation of CEBPA
Acute Myeloid Leukemia with Myelodysplasia-Related
Changes